Screener
Apogee Therapeutics, Inc. APGE Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Apogee Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The source filing: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 7:20 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-215698
| Line item | THREE MONTHS ENDEDMARCH 31, 2026 | THREE MONTHS ENDEDMARCH 31, 2025 |
|---|---|---|
| Loss from operations | (82,772) | (63,096) |
| Other income, net: | ||
| Interest income, net | 8,740 | 7,840 |
| Total other income, net | 8,740 | 7,840 |
| Net loss before taxes | (74,032) | (55,256) |
| Provision for income taxes | (79) | (83) |
| Net loss after taxes | $(74,111) | $(55,339) |
| Net loss per share, basic and diluted | $(1.06) | $(0.95) |
Item 6. [Exhibits](#item_6_exhibits) [71](#item_6_exhibits)
FAQ
- What is Apogee Therapeutics, Inc.'s other income (expense)?
- Apogee Therapeutics, Inc. (APGE) reported other income (expense) of $8.74M in Q1 2026.
- How has Apogee Therapeutics, Inc.'s other income (expense) changed year-over-year?
- Apogee Therapeutics, Inc.'s other income (expense) increased by 11.5% year-over-year, from $7.84M to $8.74M.
- What is the long-term trend for Apogee Therapeutics, Inc.'s other income (expense)?
- Over 2 years (2023 to 2025), Apogee Therapeutics, Inc.'s other income (expense) has grown at a 82.5% compound annual growth rate (CAGR), from $9.02M to $30.03M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about Apogee Therapeutics, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude